• レポートコード:GIR-2104Z11086 • 出版社/出版日:GlobalInfoResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態:英文、PDF、103ページ • 納品方法:Eメール(納期:2~3日) • 産業分類:医療 |
Single User | ¥487,200 (USD3,480) | ▷ お問い合わせ |
Multi User | ¥730,800 (USD5,220) | ▷ お問い合わせ |
Corporate User | ¥974,400 (USD6,960) | ▷ お問い合わせ |
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
当調査資料では、ポイントオブケア遺伝子検査のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。ポイントオブケア遺伝子検査の種類別市場規模(POCTがんキット、分子POCキット、抗生物質療法におけるPOCT、アッセイカートリッジ、その他)、用途別市場規模(診断研究所、バイオ製薬産業、学術機関、その他)、地域別市場規模(北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど)、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・ポイントオブケア遺伝子検査の市場概要 ・企業情報(企業概要、製品概要、販売量、価格、売上):Abbott (US)、Roche (Switzerland)、Thermo Fisher Scientific (US)、Cepheid (US)、IQuum (US)、Biocartis (Switzerland)、Idaho Technologies (US)、Optigene (UK)、Lumora (UK) ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年:POCTがんキット、分子POCキット、抗生物質療法におけるPOCT、アッセイカートリッジ、その他 ・用途別分析2016年-2026年:診断研究所、バイオ製薬産業、学術機関、その他 ・ポイントオブケア遺伝子検査の北米市場規模2016年-2026年:アメリカ、カナダ、メキシコ ・ポイントオブケア遺伝子検査のヨーロッパ市場規模2016年-2026年:ドイツ、イギリス、フランス、ロシア、イタリア ・ポイントオブケア遺伝子検査のアジア市場規模2016年-2026年:中国、日本、韓国、インド、東南アジア、オーストラリア ・ポイントオブケア遺伝子検査の南米市場規模2016年-2026年:ブラジル、アルゼンチン ・ポイントオブケア遺伝子検査の中東・アフリカ市場規模2016年-2026年:サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Point-of-Care Genetic Testing market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Point-of-Care Genetic Testing size is estimated to be USD xx million in 2025 from USD xx million in 2019, with a change XX% between 2019 and 2020. The global Point-of-Care Genetic Testing market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Point-of-Care Genetic Testing market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
POCT Cancer Kits
Molecular POC Kits
POCT In Antibiotic Therapies
Assay Cartridge
Other
Market segment by Application, can be divided into
Diagnostic Labs
Bio-Pharmaceutical Industry
Academic Institutions
Other
Market segment by players, this report covers
Abbott (US)
Roche (Switzerland)
Thermo Fisher Scientific (US)
Cepheid (US)
IQuum (US)
Biocartis (Switzerland)
Idaho Technologies (US)
Optigene (UK)
Lumora (UK)
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
1 Market Overview
1.1 Product Overview and Scope of Point-of-Care Genetic Testing
1.2 Classification of Point-of-Care Genetic Testing by Type
1.2.1 Overview: Global Point-of-Care Genetic Testing Market Size by Type: 2020 Versus 2021 Versus 2026
1.2.2 Global Point-of-Care Genetic Testing Revenue Market Share by Type in 2020
1.2.3 POCT Cancer Kits
1.2.4 Molecular POC Kits
1.2.5 POCT In Antibiotic Therapies
1.2.6 Assay Cartridge
1.2.7 Other
1.3 Global Point-of-Care Genetic Testing Market by Application
1.3.1 Overview: Global Point-of-Care Genetic Testing Market Size by Application: 2020 Versus 2021 Versus 2026
1.3.2 Diagnostic Labs
1.3.3 Bio-Pharmaceutical Industry
1.3.4 Academic Institutions
1.3.5 Other
1.4 Global Point-of-Care Genetic Testing Market Size & Forecast
1.5 Global Point-of-Care Genetic Testing Market Size and Forecast by Region
1.5.1 Global Point-of-Care Genetic Testing Market Size by Region: 2016 VS 2021 VS 2026
1.5.2 Global Point-of-Care Genetic Testing Market Size by Region, (2016-2021)
1.5.3 North America Point-of-Care Genetic Testing Market Size and Prospect (2016-2026)
1.5.4 Europe Point-of-Care Genetic Testing Market Size and Prospect (2016-2026)
1.5.5 Asia-Pacific Point-of-Care Genetic Testing Market Size and Prospect (2016-2026)
1.5.6 South America Point-of-Care Genetic Testing Market Size and Prospect (2016-2026)
1.5.7 Middle East and Africa Point-of-Care Genetic Testing Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
1.6.1 Point-of-Care Genetic Testing Market Drivers
1.6.2 Point-of-Care Genetic Testing Market Restraints
1.6.3 Point-of-Care Genetic Testing Trends Analysis
2 Company Profiles
2.1 Abbott (US)
2.1.1 Abbott (US) Details
2.1.2 Abbott (US) Major Business
2.1.3 Abbott (US) Point-of-Care Genetic Testing Product and Solutions
2.1.4 Abbott (US) Point-of-Care Genetic Testing Revenue, Gross Margin and Market Share (2019-2021)
2.1.5 Abbott (US) Recent Developments and Future Plans
2.2 Roche (Switzerland)
2.2.1 Roche (Switzerland) Details
2.2.2 Roche (Switzerland) Major Business
2.2.3 Roche (Switzerland) Point-of-Care Genetic Testing Product and Solutions
2.2.4 Roche (Switzerland) Point-of-Care Genetic Testing Revenue, Gross Margin and Market Share (2019-2021)
2.2.5 Roche (Switzerland) Recent Developments and Future Plans
2.3 Thermo Fisher Scientific (US)
2.3.1 Thermo Fisher Scientific (US) Details
2.3.2 Thermo Fisher Scientific (US) Major Business
2.3.3 Thermo Fisher Scientific (US) Point-of-Care Genetic Testing Product and Solutions
2.3.4 Thermo Fisher Scientific (US) Point-of-Care Genetic Testing Revenue, Gross Margin and Market Share (2019-2021)
2.3.5 Thermo Fisher Scientific (US) Recent Developments and Future Plans
2.4 Cepheid (US)
2.4.1 Cepheid (US) Details
2.4.2 Cepheid (US) Major Business
2.4.3 Cepheid (US) Point-of-Care Genetic Testing Product and Solutions
2.4.4 Cepheid (US) Point-of-Care Genetic Testing Revenue, Gross Margin and Market Share (2019-2021)
2.4.5 Cepheid (US) Recent Developments and Future Plans
2.5 IQuum (US)
2.5.1 IQuum (US) Details
2.5.2 IQuum (US) Major Business
2.5.3 IQuum (US) Point-of-Care Genetic Testing Product and Solutions
2.5.4 IQuum (US) Point-of-Care Genetic Testing Revenue, Gross Margin and Market Share (2019-2021)
2.5.5 IQuum (US) Recent Developments and Future Plans
2.6 Biocartis (Switzerland)
2.6.1 Biocartis (Switzerland) Details
2.6.2 Biocartis (Switzerland) Major Business
2.6.3 Biocartis (Switzerland) Point-of-Care Genetic Testing Product and Solutions
2.6.4 Biocartis (Switzerland) Point-of-Care Genetic Testing Revenue, Gross Margin and Market Share (2019-2021)
2.6.5 Biocartis (Switzerland) Recent Developments and Future Plans
2.7 Idaho Technologies (US)
2.7.1 Idaho Technologies (US) Details
2.7.2 Idaho Technologies (US) Major Business
2.7.3 Idaho Technologies (US) Point-of-Care Genetic Testing Product and Solutions
2.7.4 Idaho Technologies (US) Point-of-Care Genetic Testing Revenue, Gross Margin and Market Share (2019-2021)
2.7.5 Idaho Technologies (US) Recent Developments and Future Plans
2.8 Optigene (UK)
2.8.1 Optigene (UK) Details
2.8.2 Optigene (UK) Major Business
2.8.3 Optigene (UK) Point-of-Care Genetic Testing Product and Solutions
2.8.4 Optigene (UK) Point-of-Care Genetic Testing Revenue, Gross Margin and Market Share (2019-2021)
2.8.5 Optigene (UK) Recent Developments and Future Plans
2.9 Lumora (UK)
2.9.1 Lumora (UK) Details
2.9.2 Lumora (UK) Major Business
2.9.3 Lumora (UK) Point-of-Care Genetic Testing Product and Solutions
2.9.4 Lumora (UK) Point-of-Care Genetic Testing Revenue, Gross Margin and Market Share (2019-2021)
2.9.5 Lumora (UK) Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Point-of-Care Genetic Testing Revenue and Share by Players (2019-2021)
3.2 Market Concentration Rate
3.2.1 Top 5 Point-of-Care Genetic Testing Players Market Share
3.2.2 Top 10 Point-of-Care Genetic Testing Players Market Share
3.2.3 Market Competition Trend
3.3 Point-of-Care Genetic Testing Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Point-of-Care Genetic Testing Revenue and Market Share by Type (2016-2021)
4.2 Global Point-of-Care Genetic Testing Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
5.1 Global Point-of-Care Genetic Testing Revenue Market Share by Application (2016-2021)
5.2 Point-of-Care Genetic Testing Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
6.1 North America Point-of-Care Genetic Testing Revenue by Type (2016-2026)
6.2 North America Point-of-Care Genetic Testing Revenue by Application (2016-2026)
6.3 North America Point-of-Care Genetic Testing Market Size by Country
6.3.1 North America Point-of-Care Genetic Testing Revenue by Country (2016-2026)
6.3.2 United States Point-of-Care Genetic Testing Market Size and Forecast (2016-2026)
6.3.3 Canada Point-of-Care Genetic Testing Market Size and Forecast (2016-2026)
6.3.4 Mexico Point-of-Care Genetic Testing Market Size and Forecast (2016-2026)
7 Europe by Country, by Type, and by Application
7.1 Europe Point-of-Care Genetic Testing Revenue by Type (2016-2026)
7.2 Europe Point-of-Care Genetic Testing Revenue by Application (2016-2026)
7.3 Europe Point-of-Care Genetic Testing Market Size by Country
7.3.1 Europe Point-of-Care Genetic Testing Revenue by Country (2016-2026)
7.3.2 Germany Point-of-Care Genetic Testing Market Size and Forecast (2016-2026)
7.3.3 France Point-of-Care Genetic Testing Market Size and Forecast (2016-2026)
7.3.4 United Kingdom Point-of-Care Genetic Testing Market Size and Forecast (2016-2026)
7.3.5 Russia Point-of-Care Genetic Testing Market Size and Forecast (2016-2026)
7.3.6 Italy Point-of-Care Genetic Testing Market Size and Forecast (2016-2026)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Point-of-Care Genetic Testing Revenue by Type (2016-2026)
8.2 Asia-Pacific Point-of-Care Genetic Testing Revenue by Application (2016-2026)
8.3 Asia-Pacific Point-of-Care Genetic Testing Market Size by Region
8.3.1 Asia-Pacific Point-of-Care Genetic Testing Revenue by Region (2016-2026)
8.3.2 China Point-of-Care Genetic Testing Market Size and Forecast (2016-2026)
8.3.3 Japan Point-of-Care Genetic Testing Market Size and Forecast (2016-2026)
8.3.4 South Korea Point-of-Care Genetic Testing Market Size and Forecast (2016-2026)
8.3.5 India Point-of-Care Genetic Testing Market Size and Forecast (2016-2026)
8.3.6 Southeast Asia Point-of-Care Genetic Testing Market Size and Forecast (2016-2026)
8.3.7 Australia Point-of-Care Genetic Testing Market Size and Forecast (2016-2026)
9 South America by Country, by Type, and by Application
9.1 South America Point-of-Care Genetic Testing Revenue by Type (2016-2026)
9.2 South America Point-of-Care Genetic Testing Revenue by Application (2016-2026)
9.3 South America Point-of-Care Genetic Testing Market Size by Country
9.3.1 South America Point-of-Care Genetic Testing Revenue by Country (2016-2026)
9.3.2 Brazil Point-of-Care Genetic Testing Market Size and Forecast (2016-2026)
9.3.3 Argentina Point-of-Care Genetic Testing Market Size and Forecast (2016-2026)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Point-of-Care Genetic Testing Revenue by Type (2016-2026)
10.2 Middle East & Africa Point-of-Care Genetic Testing Revenue by Application (2016-2026)
10.3 Middle East & Africa Point-of-Care Genetic Testing Market Size by Country
10.3.1 Middle East & Africa Point-of-Care Genetic Testing Revenue by Country (2016-2026)
10.3.2 Turkey Point-of-Care Genetic Testing Market Size and Forecast (2016-2026)
10.3.3 Saudi Arabia Point-of-Care Genetic Testing Market Size and Forecast (2016-2026)
10.3.4 UAE Point-of-Care Genetic Testing Market Size and Forecast (2016-2026)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
Table 1. Global Point-of-Care Genetic Testing Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
Table 2. Global Point-of-Care Genetic Testing Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
Table 3. Global Market Point-of-Care Genetic Testing Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
Table 4. Global Point-of-Care Genetic Testing Revenue (USD Million) by Region (2016-2021)
Table 5. Global Point-of-Care Genetic Testing Revenue Market Share by Region (2021-2026)
Table 6. Abbott (US) Corporate Information, Head Office, and Major Competitors
Table 7. Abbott (US) Major Business
Table 8. Abbott (US) Point-of-Care Genetic Testing Product and Solutions
Table 9. Abbott (US) Point-of-Care Genetic Testing Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 10. Roche (Switzerland) Corporate Information, Head Office, and Major Competitors
Table 11. Roche (Switzerland) Major Business
Table 12. Roche (Switzerland) Point-of-Care Genetic Testing Product and Solutions
Table 13. Roche (Switzerland) Point-of-Care Genetic Testing Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 14. Thermo Fisher Scientific (US) Corporate Information, Head Office, and Major Competitors
Table 15. Thermo Fisher Scientific (US) Major Business
Table 16. Thermo Fisher Scientific (US) Point-of-Care Genetic Testing Product and Solutions
Table 17. Thermo Fisher Scientific (US) Point-of-Care Genetic Testing Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 18. Cepheid (US) Corporate Information, Head Office, and Major Competitors
Table 19. Cepheid (US) Major Business
Table 20. Cepheid (US) Point-of-Care Genetic Testing Product and Solutions
Table 21. Cepheid (US) Point-of-Care Genetic Testing Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 22. IQuum (US) Corporate Information, Head Office, and Major Competitors
Table 23. IQuum (US) Major Business
Table 24. IQuum (US) Point-of-Care Genetic Testing Product and Solutions
Table 25. IQuum (US) Point-of-Care Genetic Testing Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 26. Biocartis (Switzerland) Corporate Information, Head Office, and Major Competitors
Table 27. Biocartis (Switzerland) Major Business
Table 28. Biocartis (Switzerland) Point-of-Care Genetic Testing Product and Solutions
Table 29. Biocartis (Switzerland) Point-of-Care Genetic Testing Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 30. Idaho Technologies (US) Corporate Information, Head Office, and Major Competitors
Table 31. Idaho Technologies (US) Major Business
Table 32. Idaho Technologies (US) Point-of-Care Genetic Testing Product and Solutions
Table 33. Idaho Technologies (US) Point-of-Care Genetic Testing Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 34. Optigene (UK) Corporate Information, Head Office, and Major Competitors
Table 35. Optigene (UK) Major Business
Table 36. Optigene (UK) Point-of-Care Genetic Testing Product and Solutions
Table 37. Optigene (UK) Point-of-Care Genetic Testing Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 38. Lumora (UK) Corporate Information, Head Office, and Major Competitors
Table 39. Lumora (UK) Major Business
Table 40. Lumora (UK) Point-of-Care Genetic Testing Product and Solutions
Table 41. Lumora (UK) Point-of-Care Genetic Testing Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 42. Global Point-of-Care Genetic Testing Revenue (USD Million) by Players (2019-2021)
Table 43. Global Point-of-Care Genetic Testing Revenue Share by Players (2019-2021)
Table 44. Breakdown of Point-of-Care Genetic Testing by Company Type (Tier 1, Tier 2 and Tier 3)
Table 45. Point-of-Care Genetic Testing Players Head Office, Products and Services Provided
Table 46. Point-of-Care Genetic Testing Mergers & Acquisitions in the Past Five Years
Table 47. Point-of-Care Genetic Testing New Entrants and Expansion Plans
Table 48. Global Point-of-Care Genetic Testing Revenue (USD Million) by Type (2016-2021)
Table 49. Global Point-of-Care Genetic Testing Revenue Share by Type (2016-2021)
Table 50. Global Point-of-Care Genetic Testing Revenue Forecast by Type (2021-2026)
Table 51. Global Point-of-Care Genetic Testing Revenue by Application (2016-2021)
Table 52. Global Point-of-Care Genetic Testing Revenue Forecast by Application (2021-2026)
Table 53. North America Point-of-Care Genetic Testing Revenue by Type (2016-2021) & (USD Million)
Table 54. North America Point-of-Care Genetic Testing Revenue by Type (2021-2026) & (USD Million)
Table 55. North America Point-of-Care Genetic Testing Revenue by Application (2016-2021) & (USD Million)
Table 56. North America Point-of-Care Genetic Testing Revenue by Application (2021-2026) & (USD Million)
Table 57. North America Point-of-Care Genetic Testing Revenue by Country (2016-2021) & (USD Million)
Table 58. North America Point-of-Care Genetic Testing Revenue by Country (2021-2026) & (USD Million)
Table 59. Europe Point-of-Care Genetic Testing Revenue by Type (2016-2021) & (USD Million)
Table 60. Europe Point-of-Care Genetic Testing Revenue by Type (2021-2026) & (USD Million)
Table 61. Europe Point-of-Care Genetic Testing Revenue by Application (2016-2021) & (USD Million)
Table 62. Europe Point-of-Care Genetic Testing Revenue by Application (2021-2026) & (USD Million)
Table 63. Europe Point-of-Care Genetic Testing Revenue by Country (2016-2021) & (USD Million)
Table 64. Europe Point-of-Care Genetic Testing Revenue by Country (2021-2026) & (USD Million)
Table 65. Asia-Pacific Point-of-Care Genetic Testing Revenue by Type (2016-2021) & (USD Million)
Table 66. Asia-Pacific Point-of-Care Genetic Testing Revenue by Type (2021-2026) & (USD Million)
Table 67. Asia-Pacific Point-of-Care Genetic Testing Revenue by Application (2016-2021) & (USD Million)
Table 68. Asia-Pacific Point-of-Care Genetic Testing Revenue by Application (2021-2026) & (USD Million)
Table 69. Asia-Pacific Point-of-Care Genetic Testing Revenue by Region (2016-2021) & (USD Million)
Table 70. Asia-Pacific Point-of-Care Genetic Testing Revenue by Region (2021-2026) & (USD Million)
Table 71. South America Point-of-Care Genetic Testing Revenue by Type (2016-2021) & (USD Million)
Table 72. South America Point-of-Care Genetic Testing Revenue by Type (2021-2026) & (USD Million)
Table 73. South America Point-of-Care Genetic Testing Revenue by Application (2016-2021) & (USD Million)
Table 74. South America Point-of-Care Genetic Testing Revenue by Application (2021-2026) & (USD Million)
Table 75. South America Point-of-Care Genetic Testing Revenue by Country (2016-2021) & (USD Million)
Table 76. South America Point-of-Care Genetic Testing Revenue by Country (2021-2026) & (USD Million)
Table 77. Middle East & Africa Point-of-Care Genetic Testing Revenue by Type (2016-2021) & (USD Million)
Table 78. Middle East & Africa Point-of-Care Genetic Testing Revenue by Type (2021-2026) & (USD Million)
Table 79. Middle East & Africa Point-of-Care Genetic Testing Revenue by Application (2016-2021) & (USD Million)
Table 80. Middle East & Africa Point-of-Care Genetic Testing Revenue by Application (2021-2026) & (USD Million)
Table 81. Middle East & Africa Point-of-Care Genetic Testing Revenue by Country (2016-2021) & (USD Million)
Table 82. Middle East & Africa Point-of-Care Genetic Testing Revenue by Country (2021-2026) & (USD Million)
List of Figures
Figure 1. Point-of-Care Genetic Testing Picture
Figure 2. Global Point-of-Care Genetic Testing Revenue Market Share by Type in 2020
Figure 3. POCT Cancer Kits
Figure 4. Molecular POC Kits
Figure 5. POCT In Antibiotic Therapies
Figure 6. Assay Cartridge
Figure 7. Other
Figure 8. Point-of-Care Genetic Testing Revenue Market Share by Application in 2020
Figure 9. Diagnostic Labs Picture
Figure 10. Bio-Pharmaceutical Industry Picture
Figure 11. Academic Institutions Picture
Figure 12. Other Picture
Figure 13. Global Point-of-Care Genetic Testing Revenue, (USD Million): 2020 VS 2021 VS 2026
Figure 14. Global Point-of-Care Genetic Testing Revenue and Forecast (2016-2026) & (USD Million)
Figure 15. Global Point-of-Care Genetic Testing Revenue Market Share by Region (2016-2026)
Figure 16. Global Point-of-Care Genetic Testing Revenue Market Share by Region in 2020
Figure 17. North America Point-of-Care Genetic Testing Revenue (USD Million) and Growth Rate (2016-2026)
Figure 18. Europe Point-of-Care Genetic Testing Revenue (USD Million) and Growth Rate (2016-2026)
Figure 19. Asia-Pacific Point-of-Care Genetic Testing Revenue (USD Million) and Growth Rate (2016-2026)
Figure 20. South America Point-of-Care Genetic Testing Revenue (USD Million) and Growth Rate (2016-2026)
Figure 21. Point-of-Care Genetic Testing Market Drivers
Figure 22. Point-of-Care Genetic Testing Market Restraints
Figure 23. Point-of-Care Genetic Testing Market Trends
Figure 24. Abbott (US) Recent Developments and Future Plans
Figure 25. Roche (Switzerland) Recent Developments and Future Plans
Figure 26. Thermo Fisher Scientific (US) Recent Developments and Future Plans
Figure 27. Cepheid (US) Recent Developments and Future Plans
Figure 28. IQuum (US) Recent Developments and Future Plans
Figure 29. Biocartis (Switzerland) Recent Developments and Future Plans
Figure 30. Idaho Technologies (US) Recent Developments and Future Plans
Figure 31. Optigene (UK) Recent Developments and Future Plans
Figure 32. Lumora (UK) Recent Developments and Future Plans
Figure 34. Global Point-of-Care Genetic Testing Revenue Share by Players in 2020
Figure 35. Point-of-Care Genetic Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 36. Global Top 3 Players Point-of-Care Genetic Testing Revenue Market Share in 2020
Figure 37. Global Top 10 Players Point-of-Care Genetic Testing Revenue Market Share in 2020
Figure 38. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
Figure 39. Global Point-of-Care Genetic Testing Revenue Share by Type in 2020
Figure 40. Global Point-of-Care Genetic Testing Market Share Forecast by Type (2021-2026)
Figure 41. Global Point-of-Care Genetic Testing Revenue Share by Application in 2020
Figure 42. Global Point-of-Care Genetic Testing Market Share Forecast by Application (2021-2026)
Figure 43. North America Point-of-Care Genetic Testing Sales Market Share by Type (2016-2026)
Figure 44. North America Point-of-Care Genetic Testing Sales Market Share by Application (2016-2026)
Figure 45. North America Point-of-Care Genetic Testing Revenue Market Share by Country (2016-2026)
Figure 46. United States Point-of-Care Genetic Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 47. Canada Point-of-Care Genetic Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 48. Mexico Point-of-Care Genetic Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 49. Europe Point-of-Care Genetic Testing Sales Market Share by Type (2016-2026)
Figure 50. Europe Point-of-Care Genetic Testing Sales Market Share by Application (2016-2026)
Figure 51. Europe Point-of-Care Genetic Testing Revenue Market Share by Country (2016-2026)
Figure 52. Germany Point-of-Care Genetic Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 53. France Point-of-Care Genetic Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 54. United Kingdom Point-of-Care Genetic Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 55. Russia Point-of-Care Genetic Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 56. Italy Point-of-Care Genetic Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 57. Asia-Pacific Point-of-Care Genetic Testing Sales Market Share by Type (2016-2026)
Figure 58. Asia-Pacific Point-of-Care Genetic Testing Sales Market Share by Application (2016-2026)
Figure 59. Asia-Pacific Point-of-Care Genetic Testing Revenue Market Share by Region (2016-2026)
Figure 60. China Point-of-Care Genetic Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. Japan Point-of-Care Genetic Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. South Korea Point-of-Care Genetic Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 63. India Point-of-Care Genetic Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 64. Southeast Asia Point-of-Care Genetic Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 65. Australia Point-of-Care Genetic Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 66. South America Point-of-Care Genetic Testing Sales Market Share by Type (2016-2026)
Figure 67. South America Point-of-Care Genetic Testing Sales Market Share by Application (2016-2026)
Figure 68. South America Point-of-Care Genetic Testing Revenue Market Share by Country (2016-2026)
Figure 69. Brazil Point-of-Care Genetic Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 70. Argentina Point-of-Care Genetic Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 71. Middle East and Africa Point-of-Care Genetic Testing Sales Market Share by Type (2016-2026)
Figure 72. Middle East and Africa Point-of-Care Genetic Testing Sales Market Share by Application (2016-2026)
Figure 73. Middle East and Africa Point-of-Care Genetic Testing Revenue Market Share by Country (2016-2026)
Figure 74. Turkey Point-of-Care Genetic Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 75. Saudi Arabia Point-of-Care Genetic Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 76. UAE Point-of-Care Genetic Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 77. Methodology
Figure 78. Research Process and Data Source